CoQ10 Supplement for Fertility: Dose, Form, and Timing

You are thirty-four, thirty-six, perhaps forty, or you have been told your anti-Müllerian hormone (AMH) is on the lower side, and you have read that every fertility doctor recommends a CoQ10 supplement for fertility. You want to know if the evidence is real, what dose, what form, and whether the eight-pound bottle from the high street is the same as the forty-five-pound ubiquinol from the IVF forums. The short answer: CoQ10 has a plausible mechanism and modest supporting evidence for age-related egg quality decline and diminished ovarian reserve. It is not a generic fertility booster. Most people under thirty with normal reserve do not need it.

I want to write this post honestly because CoQ10 sits in an awkward middle place in the supplement world. It is not snake oil; it has a real mechanistic anchor and small trials supporting selective use. It is also not a guaranteed intervention with a known live-birth benefit. Both halves of that sentence matter, and I will try to keep both visible throughout.

Why CoQ10 made it into fertility conversations

Coenzyme Q10 (CoQ10, also called ubiquinone in its oxidised form and ubiquinol in its reduced form) is essential to mitochondrial ATP production. Every cell with a mitochondrion uses it. Oocytes (eggs) are uniquely mitochondria-dense: a single mature human egg holds more than one hundred thousand mitochondria, which is far more than almost any other cell type in the body. Those mitochondria fuel meiosis, fertilisation, early cleavage, and the energetic demands of embryo development.

Mitochondrial dysfunction is one of the better-supported mechanisms behind the age-related decline in egg quality and the rise in aneuploidy after the mid-thirties. As oocytes age, their mitochondria accumulate damage, their CoQ10 content declines, and their energetic output drops. That biology is well established. The question for fertility care is whether external CoQ10 supplementation crosses into the oocyte, raises mitochondrial function, and produces a clinical benefit large enough to measure.

The mechanistic anchor most people cite is the Ben-Meir study published in Aging Cell in 2015.¹ In aged female mice, CoQ10 supplementation restored oocyte mitochondrial function. It also increased the number of ovulated oocytes and improved spindle morphology. The biology was clean. The translation to humans is where the picture gets fuzzier.

What the human evidence actually shows

The human evidence base is real but modest. A summary of where it lands in 2026:

• Small randomised trials in IVF: Bentov and colleagues (2014) reported improved fertilisation rates and embryo quality in women over thirty-five receiving CoQ10 before in vitro fertilisation (IVF), with small sample sizes.² Xu and colleagues (2018) randomised young women with documented low ovarian reserve (poor responders) to CoQ10 pretreatment and found improved ovarian response and embryo quality.³ Live birth was not the primary outcome in either.
• Cochrane systematic review (2020): Showell and colleagues' review of antioxidants for female subfertility included CoQ10 and found low-quality evidence suggesting it may improve clinical pregnancy rate. Live-birth data were limited and uncertain.⁴
• Florou meta-analysis (2020): Pooled assisted reproductive technology (ART) outcomes and found a possible improvement in clinical pregnancy with CoQ10 pretreatment in women with diminished ovarian reserve, with low-to-moderate certainty.⁵
• ESHRE add-ons guidance (2023): The European Society of Human Reproduction and Embryology classified CoQ10 as "research only" or "neutral, not against" in their good practice recommendations on IVF add-ons.⁶ That places it in the category of: not actively recommended as routine, not strongly contraindicated, reasonable to discuss case-by-case.

The honest framing, the one I use with patients in clinic, is that CoQ10 is real, plausible, and modest. It is not a cure for age-related infertility. It is not a substitute for IVF when IVF is what is indicated. And it is not the priority intervention for everyone trying to conceive.

Who a CoQ10 supplement for fertility is more likely to help

Selection matters more for CoQ10 than for most preconception supplements. The cohorts in which the evidence sits, and where I am most likely to suggest it, are:

• Women age 35 and over trying naturally or doing medicated cycles. The age-related decline in oocyte mitochondrial function is the underlying biological rationale.
• Documented diminished ovarian reserve (DOR): Low AMH, raised follicle-stimulating hormone (FSH), low antral follicle count (AFC), or POSEIDON-criteria poor prognosis. This is where Xu and colleagues showed a measurable signal.
• Prior poor responders in IVF: Patients with a previous cycle producing few mature oocytes, particularly under standard or maximal stimulation. CoQ10 is sometimes added to the next stimulation protocol as a pretreatment.
• Patients on long-term statins: Statins reduce circulating CoQ10 by inhibiting a shared pathway. This is not a fertility-specific indication, but it is worth knowing if you are on one.

Who CoQ10 is less likely to help

The flip side, the cohorts where I do not put CoQ10 on the recommended list:

• Under 30 with normal cycles and no reserve concerns: No measurable benefit expected, and the money is better spent on a good prenatal, a vitamin D top-up, and confirming dietary patterns. CoQ10 in this group is a reassurance purchase, not a clinical one.
• PCOS as the primary diagnosis: The priority supplement here is myo-inositol, not CoQ10. PCOS-related infertility is driven by anovulation and insulin signalling, not primarily by mitochondrial decline. CoQ10 can be added on if other indications coexist, but it is not the headline. For the full PCOS-fertility supplement framing, see myo-inositol and D-chiro inositol for PCOS.
• Severe male-factor infertility: A different evidence base. CoQ10 has been studied for sperm parameters, and that is a separate post: see CoQ10 for male fertility.
• As a substitute for clinically indicated treatment: If your reproductive endocrinologist has recommended starting medicated cycles or IVF, CoQ10 does not replace the recommendation. It can sit alongside it.

What I tell my thirty-six-year-old patients who are starting medicated cycles or planning IVF is to consider 200 to 400 milligrams of CoQ10 with a fatty meal for ninety days before the cycle. That is the cohort where the evidence is least thin and the cost-benefit is reasonable.

Dose, form, and timing

Dose

Trials in the female egg-quality indication have used CoQ10 doses ranging from 100 to 600 milligrams daily. The most common doses in IVF pretreatment protocols are 200 to 400 milligrams. The Xu RCT in poor responders used 200 milligrams three times daily (600 milligrams total). The Bentov pilot work used 600 milligrams.

A reasonable lower end is 200 milligrams daily. A reasonable upper end is 600 milligrams daily, taken in divided doses with food. Pushing higher than 800 milligrams adds cost without adding evidence of benefit, and the marketing temptation to take "more, just in case" is the wrong instinct here. The most-studied CoQ10 dose fertility range sits in the 200 to 400 milligram band for most users.

Ubiquinone versus ubiquinol

This is the form question most people get stuck on.

Ubiquinone is the oxidised form. It is the form used in most of the older trials, it is cheaper, and it is well absorbed in healthy adults with normal gut function.

Ubiquinol is the reduced form. It is more expensive (often two to three times the price), and it may be better absorbed in some people, particularly over the age of forty or with conditions affecting gut absorption. The body interconverts between ubiquinone and ubiquinol continuously, so the practical difference is smaller than the marketing implies.

A pragmatic position: under forty with normal absorption, ubiquinone 200 to 400 milligrams is fine and is what most of the trial data are based on. Over forty, doing IVF, or with gut absorption concerns, ubiquinol 200 to 400 milligrams is a reasonable choice. The form is a secondary variable. The bigger one is whether you actually take it consistently for ninety days.

Timing

Egg quality reflects the antral phase of folliculogenesis, which is roughly the ninety days during which the follicle that will eventually ovulate is maturing. If you want CoQ10 to influence the cycle in which you ovulate or do a retrieval, you need to start it at least sixty to ninety days before that cycle. Starting two weeks before a retrieval is too late to act on the follicles that matter.

CoQ10 is fat-soluble. Absorption can roughly triple when it is taken with a meal containing fat compared to on an empty stomach. Take it with breakfast or dinner, not with water in isolation. This is one of the rare cases where the "take with food" instruction has a measurable absorption consequence.

Cost honesty

A reasonable monthly cost for a CoQ10 supplement for fertility:

• 200 to 400 milligrams of ubiquinone: roughly fifteen to thirty pounds a month.
• 200 to 400 milligrams of ubiquinol: roughly thirty to sixty pounds a month.
• "Fertility-branded" CoQ10 in a pink bottle: typically two to three times the equivalent generic, with no formulation advantage that maps to better trial outcomes.

If your CoQ10 is costing you more than sixty pounds a month, check the back of the bottle. You are usually paying for branding, not for a different molecule.

What to do tonight

The practical decision tree:

1. Are you under 30 with regular cycles and no reserve concerns? Skip CoQ10. Spend on a complete prenatal multivitamin and fix vitamin D if it is low.
2. Are you 35 or older, have documented diminished ovarian reserve, are a prior poor responder, or are preparing for IVF? Start CoQ10 at 200 to 400 milligrams daily with a fatty meal. Use ubiquinone if you are under forty; consider ubiquinol if you are forty plus or have gut absorption concerns.
3. Set a daily anchor: take it with the same meal every day. Ninety days of imperfect adherence beats two weeks of perfect adherence.
4. Re-evaluate at the start of your trying cycle or retrieval: CoQ10 is a pretreatment supplement, not a long-term forever supplement; if your cycle ends in conception, you do not need to continue it through pregnancy.

The other useful exercise tonight is to ask, plainly: do I have an indication, or am I taking this because someone with a different fertility profile recommended it to me? If you cannot name an indication, the money is probably better spent elsewhere.

When to talk to your clinician about CoQ10

A few situations warrant a clinician conversation before starting.

• You are doing IVF in the next sixty to ninety days: some clinics include CoQ10 in their stimulation protocol; some do not. Ask before doubling up, and let the embryology team know what you are taking.
• You are on warfarin or another vitamin K antagonist: CoQ10 has structural similarity to vitamin K and may slightly affect international normalised ratio (INR). Discuss timing and dose with your anticoagulation team.
• You are on statins or beta-blockers: your endogenous CoQ10 levels may already be lower. The clinical relevance is unclear, but worth flagging.
• You have a pre-existing arrhythmia or heart-rhythm condition: mention CoQ10 to your cardiologist before starting.
• Pregnancy: once you conceive, the role of CoQ10 changes. There is no clear indication to continue it through pregnancy. I generally tell patients to stop a CoQ10 supplement for fertility at a positive test unless their team has specifically said to continue.

What's next

• For the full female preconception stack: read the preconception supplement stack.
• If you have PCOS rather than age-related concerns: read myo-inositol and D-chiro inositol for PCOS fertility.
• For your partner's CoQ10 question, particularly with male-factor concerns: read CoQ10 for male fertility.
• For age and ovarian reserve framing: see the diagnosis-section posts on AMH, FSH, and antral follicle count.
• If you are heading into IVF: the section hub for IVF covers the broader prep window.

Sources

1. Ben-Meir A, Burstein E, Borrego-Alvarez A, et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell 2015;14(5):887-895. Link
2. Bentov Y, Hannam T, Jurisicova A, Esfandiari N, Casper RF. Coenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF-ICSI treatment. Clin Med Insights Reprod Health 2014;8:31-36. Link
3. Xu Y, Nisenblat V, Lu C, Li R, Qiao J, Zhen X, Wang S. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol 2018;16(1):29. Link
4. Showell MG, Mackenzie-Proctor R, Jordan V, Hart RJ. Antioxidants for female subfertility. Cochrane Database Syst Rev 2020;8(8):CD007807. Link
5. Florou P, Anagnostis P, Theocharis P, Chourdakis M, Goulis DG. Does coenzyme Q10 supplementation improve fertility outcomes in women undergoing assisted reproductive technology procedures? A systematic review and meta-analysis. J Assist Reprod Genet 2020;37(10):2377-2387. Link
6. ESHRE Add-ons Working Group; Lundin K, Bentzen JG, Bozdag G, et al. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod 2023;38(11):2062-2104. Link
7. Bentov Y, Esfandiari N, Burstein E, Casper RF. The use of mitochondrial nutrients to improve the outcome of infertility treatment in older patients. Fertil Steril 2010;93(1):272-275. Link